title: Life quality in patients under hypotensive treatment.
abstract: The authors studied the life quality in a group of 74 patients--31 males and 43 females--affected with essential hypertension of World Health Organization I or II degree. All patients began treatment with frusemide at a dose of 25 mg once a day. The 35 non-responsive patients to frusemide were then treated, by random selection, with captopril at a dose of 25 mg twice a day, or nadolol at a dose of 80 mg once a day, for three months. The results show no significant differences on the hypotensive effect with either drug; in view of the incidence of side-effects of the two drugs, treatment with captopril is clearly better tolerated by the patients.
authors.forename: F
authors.initials: F
authors.lastname: Pupita
authors.forename: R
authors.initials: R
authors.lastname: Ansuini
authors.forename: M
authors.initials: M
authors.lastname: Belogi
authors.forename: G
authors.initials: G
authors.lastname: Campolucci
authors.forename: S
authors.initials: S
authors.lastname: Gaggi
authors.forename: G
authors.initials: G
authors.lastname: Pupita
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000009:adverse effects*; D005260:Female; D005665:Furosemide / Q000009:adverse effects / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D009248:Nadolol / Q000009:adverse effects*; D010349:Patient Compliance; D011788:Quality of Life
chemical_list: D000959:Antihypertensive Agents; D009248:Nadolol; D005665:Furosemide; D002216:Captopril